TOKYO -- Japanese pharmaceutical company Eisai will set up a joint venture with Chinese e-commerce group JD.com to launch an online medical services business focusing on dementia in China early next year, Nikkei has learned.
Japanese pharma aims to develop new drugs based on big medical data

The joint venture between Eisai and JD.com aims to have a pool of about 2,000 dementia specialists communicating with users online. (Source photos by Rei Ishii and Reuters)
TOKYO -- Japanese pharmaceutical company Eisai will set up a joint venture with Chinese e-commerce group JD.com to launch an online medical services business focusing on dementia in China early next year, Nikkei has learned.